Showing 1 - 10 of 3,835
driving the costs of pharmaceuticals, and develop a structured vector autoregressive (SVAR) model to measure the social rate …This study examines the relationship between pharmaceutical R&D and health care expenditures, distinguishing between … patents are not correlated with higher short-run prices in any measure of medical costs. They are associated with higher long …
Persistent link: https://www.econbiz.de/10014209235
The 21st century has been a period of rising inequality in both income and health. In this study, we find that … the largest health gains during the last several decades. Nor was higher dispersion in mortality caused entirely by the … that high-income states in 1992 were better able to enact public health strategies and adopt behaviors that, over the next …
Persistent link: https://www.econbiz.de/10012661996
self-reported average out-of-pocket costs for all drugs consumed. That is, user fees reduce the use of potentially …
Persistent link: https://www.econbiz.de/10003951612
We examine the impact of new medical information on drug safety on preventive health behavior. We exploit the release … of the findings of the Women's Health Initiative Study (WHIS) - the largest randomized controlled trial of women's health … estimate the spillover effects of the WHIS findings on health behavior by means of a difference-in-differences methodology …
Persistent link: https://www.econbiz.de/10009534063
states with more nursing homes per capita, in states with more COVID-19 deaths, and with more health workers. The subset of … health workers, including physicians and nurses, did not significantly impact administration or efficiency. On the other hand …, vaccination efficiency was lower in states with a centralized public health agency. States with a larger share of the elderly …
Persistent link: https://www.econbiz.de/10013235098
states with more nursing homes per capita, in states with more COVID-19 deaths, and with more health workers. The subset of … health workers, including physicians and nurses, did not significantly impact administration or efficiency. On the other hand …, vaccination efficiency was lower in states with a centralized public health agency. States with a larger share of the elderly …
Persistent link: https://www.econbiz.de/10012494792
This paper studies price determination in pharmaceutical markets using data for 25 countries, six years and a comprehensive list of products from the MIDAS IMS database. We show that market power and the quality of the product has a significantly positive impact of prices. The nationality of the...
Persistent link: https://www.econbiz.de/10014225237
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to innovate around this...
Persistent link: https://www.econbiz.de/10013477204
treatment costs were calculated for patients covered under Medicare Part B and D. The association between log-prices and …
Persistent link: https://www.econbiz.de/10014357763
suggest a pass-through of lower production costs to retail prices, boosting patients' demand for opioids, we fail to detect …
Persistent link: https://www.econbiz.de/10012843718